Want to see IN:BALAMINES full AI Analyst Report?
Balaji Amines Limited (BALAMINES) AI Stock Analysis
Balaji Amines Limited
(NSE:BALAMINES)
The overall score reflects a financially resilient company with a very strong, low‑leverage balance sheet and reasonable but normalized profitability, offset by recent cash‑flow volatility and an expensive valuation. Technical indicators show the stock in a longer‑term uptrend but with cooling near‑term momentum, leading to a balanced, mid‑range risk‑reward profile rather than a clearly compelling entry point.
Balaji Amines Limited (BALAMINES) vs. iShares MSCI India ETF (INDA)
- Market Cap
- INR 65.91B
- Dividend Yield
- 0.63%
- Average Volume (3M)
- 16.30K
- Price to Earnings (P/E)
- 27.9
- Beta (1Y)
- 0.95
- Revenue Growth
- 11.08%
- EPS Growth
- 34.10%
- Country
- India
- Employees
- 1,266
- Sector
- General
- Sector Strength
- 55
- Industry
- Chemicals - Specialty
Balaji Amines Limited Business Overview & Revenue Model
Company Description
Balaji Amines Limited, an Indian company, specializes in the production and global distribution of methylamines, ethylamines, their associated derivatives, alongside a diverse portfolio of specialty chemicals and pharmaceutical excipients. The firm's...
How the Company Makes Money
Balaji Amines primarily makes money by manufacturing and selling chemical products—mainly aliphatic amines and amine derivatives—to industrial customers. Its core revenue stream is product sales, where earnings are driven by (a) sales volumes to dome...
Balaji Amines Limited Financial Statement Overview
Summary
Strong, low‑debt balance sheet and solid profitability support resilience, but revenue and margin volatility plus weaker recent cash generation and negative free cash flow temper the strength.
Income Statement
72PositiveBalance Sheet
88Very PositiveCash Flow
58Neutral| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.23B | 14.25B | 13.97B | 16.08B | 23.38B | 23.20B |
| Gross Profit | 6.07B | 4.88B | 4.88B | 3.50B | 8.39B | 8.57B |
| EBITDA | 3.52B | 2.92B | 2.65B | 3.53B | 6.14B | 6.37B |
| Net Income | 2.04B | 1.67B | 1.58B | 2.05B | 3.26B | 3.68B |
Balance Sheet | ||||||
| Total Assets | 0 | 27.43B | 22.52B | 21.46B | 19.63B | 18.75B |
| Cash, Cash Equivalents and Short-Term Investments | 2.70B | 2.71B | 3.50B | 3.31B | 3.09B | 515.37M |
| Total Debt | 0 | 1.33B | 110.27M | 196.97M | 575.74M | 1.01B |
| Total Liabilities | -21.52B | 5.91B | 2.34B | 2.53B | 2.65B | 5.60B |
| Stockholders Equity | 21.52B | 19.76B | 18.45B | 17.22B | 15.54B | 12.50B |
Cash Flow | ||||||
| Free Cash Flow | -1.62B | -1.74B | 874.82M | 704.14M | 2.62B | 842.07M |
| Operating Cash Flow | 222.05M | 1.96B | 2.73B | 3.34B | 3.82B | 2.32B |
| Investing Cash Flow | -1.15B | -3.58B | -1.61B | -1.64B | -1.86B | -1.47B |
| Financing Cash Flow | -169.00M | 865.75M | -447.73M | -749.66M | -812.33M | -565.13M |
Balaji Amines Limited Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:BALAMINES, the sentiment is Negative. The current price of 1764.15 is below the 20-day moving average (MA) of 1985.71, below the 50-day MA of 2156.53, and above the 200-day MA of 1713.34, indicating a neutral trend. The MACD of -97.58 indicates Positive momentum. The RSI at 31.80 is Neutral, neither overbought nor oversold. The STOCH value of 18.49 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:BALAMINES.
Balaji Amines Limited Peers Comparison
Overall Rating
IN:BALAMINES68Neutral
IN:AMNPLST66Neutral
IN:ALKYLAMINE61Neutral
IN:ANURAS49Neutral
IN:JUBLINGREA46Neutral
IN:LXCHEM46Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 68Neutral | INR 57.16B | 27.90 | ― | 0.63% | 11.08% | 34.10% | |
| 66Neutral | INR 7.87B | 20.29 | ― | 0.35% | -12.40% | -3.04% | |
| 61Neutral | INR 81.33B | 36.11 | ― | 0.63% | 5.11% | 20.64% | |
| Sector * | 55Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% |
| 49Neutral | INR 129.99B | 74.35 | ― | 0.13% | 51.77% | 36.90% | |
| 46Neutral | INR 89.05B | 25.14 | ― | 0.89% | 15.41% | 21.76% | |
| 46Neutral | INR 42.47B | 33.72 | ― | 0.20% | 5.47% | 24.88% |
* General Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| IN:BALAMINES | Balaji Amines Limited | 1764.15 | 351.10 | 24.85% | |
| IN:ALKYLAMINE | Alkyl Amines Chemicals Limited | 1590.10 | -289.30 | -15.39% | |
| IN:AMNPLST | Amines & Plasticizers Ltd. | 143.00 | -70.91 | -33.15% | |
| IN:ANURAS | Anupam Rasayan India Ltd. | 1141.80 | 61.23 | 5.67% | |
| IN:JUBLINGREA | Jubilant Ingrevia Ltd. | 559.05 | -127.98 | -18.63% | |
| IN:LXCHEM | Laxmi Organic Industries Ltd. | 152.80 | -43.86 | -22.30% |
Balaji Amines Limited Corporate Events
Balaji Amines Sees Bank Loan Credit Rating Withdrawn After Clearing Dues
Balaji Amines Limited has announced that India Ratings and Research has withdrawn the credit rating assigned to its bank loan facilities after the company obtained No Dues Certificates from all lenders. The withdrawal follows the company’s requ...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Oct 07, 2026